Max Healthcare Institute Latest Share Price (MAXHEALTH)
TODAY IN ONE LINE
MAXHEALTH slipped 0.7% on average volume, in line with Nifty's 0.1% move.
it trades at a P/E of 72.87. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Max Healthcare Institute flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Healthy Operating MarginsOPM is structurally strong at 26.8%
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 77.0x
- ●Low Promoter HoldingPromoters hold only 23.7%
- ●FII SellingFII holding decreased by 2.96% QoQ
- ●Rising Receivables vs SalesReceivables grew 51.0% outpacing sales growth of 30.0%
Latest Max Healthcare Institute News
What changed recently?
Recent events, corporate actions, and announcements.
Max Healthcare Institute Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Max Healthcare Institute Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Max Healthcare Institute Ltd trades at a P/E of 72.87× and P/B of 9.78×, against the Healthcare sector median P/E of 46.27×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Max Healthcare Institute Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Max Healthcare Institute Ltd — derived from the latest tape, not yesterday's close.
Max Healthcare Institute Ltd last traded at ₹1,072.4 with an intraday range of ₹1,064.1–₹1,079.5 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1072.40| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1110.70 | +38.30 | +3.57% |
| R3 | 1095.30 | +22.90 | +2.14% |
| R2 | 1087.40 | +15.00 | +1.40% |
| R1 | 1079.90 | +7.50 | +0.70% |
| PIVOT | 1072.00 | -0.40 | -0.04% |
| CURRENT | 1072.40 | — | — |
| S1 | 1064.50 | -7.90 | -0.74% |
| S2 | 1056.60 | -15.80 | -1.47% |
| S3 | 1049.10 | -23.30 | -2.17% |
| S4 | 1033.70 | -38.70 | -3.61% |
MAXHEALTH is trading Above CPR, indicating Bullishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹1070.9–₹1079.5
Trading Inside opening range
Max Healthcare Institute Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Max Healthcare Institute Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Max Healthcare Institute Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current reported EPS of ₹14.80.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 7,028 | 8,373 ▲ 19.1% |
| Sales Growth YoY %Derived | 30.01% | 19.14% |
| Other Income | 156 | 163 ▲ 4.5% |
| Total Income | 7,184 | 8,536 ▲ 18.8% |
| 1,477 | 1,790 ▲ 21.2% | |
| Gross ProfitDerived | 5,551 | 6,583 ▲ 18.6% |
| Gross Margin %Derived | 78.98% | 78.62% |
| 3,703 | 4,341 ▲ 17.2% | |
| EBITDA (Operating Profit)Derived | 1,849 | 2,243 ▲ 21.3% |
| OPM %Derived | 26.30% | 26.79% |
| 451 | 633 ▲ 40.5% | |
| Profit Before Tax (PBT) | 1,406 | 1,676 ▲ 19.1% |
| 330 | 233 ▼ 29.4% | |
| Effective Tax %Derived | 23.50% | 13.92% |
| Total Profit for Period | 1,076 | 1,442 ▲ 34.1% |
| Net Profit (Owner's PAT)Derived | 1,076 | 1,442 ▲ 34.1% |
| Net Profit Margin %Derived | 15.31% | 17.23% |
| PAT Growth YoY %Derived | 1.72% | 34.07% |
| Earnings Per Share (EPS ₹) | 11.07 | 14.82 ▲ 33.9% |
| Diluted Shares Outstanding (Cr) | 97 | 97 ▲ 0.1% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | -5 | -2 ▲ 65.3% |
| Total Expenses (incl. D&A & Interest) | 5,778 | 6,860 ▲ 18.7% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 16.70% | 16.21% |
| Other Cost % of RevenueDerived | 35.98% | 35.63% |
| Interest Coverage (x)Derived | 9.03x | 7.64x |
| Period | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 2,505 | 3,931 ▲ 57.0% | 4,563 ▲ 16.1% | 5,406 ▲ 18.5% | 7,028 ▲ 30.0% | 8,373 ▲ 19.1% | |
| Sales Growth YoY %Derived | — | 56.97% | 16.05% | 18.49% | 30.01% | 19.14% | |
| Other Income | 115 | 127 ▲ 11.0% | 139 ▲ 9.3% | 178 ▲ 27.9% | 156 ▼ 12.6% | 163 ▲ 4.5% | |
| Total Income | 2,619 | 4,059 ▲ 55.0% | 4,702 ▲ 15.8% | 5,584 ▲ 18.8% | 7,184 ▲ 28.7% | 8,536 ▲ 18.8% | |
594 | 923 ▲ 55.3% | 922 ▼ 0.1% | 1,119 ▲ 21.3% | 1,477 ▲ 32.1% | 1,790 ▲ 21.2% | ||
| Gross ProfitDerived | 1,910 | 3,009 ▲ 57.5% | 3,641 ▲ 21.0% | 4,288 ▲ 17.8% | 5,551 ▲ 29.5% | 6,583 ▲ 18.6% | |
| Gross Margin %Derived | 76.27% | 76.53% | 79.79% | 79.31% | 78.98% | 78.62% | |
1,506 | 2,066 ▲ 37.1% | 2,400 ▲ 16.2% | 2,795 ▲ 16.5% | 3,703 ▲ 32.5% | 4,341 ▲ 17.2% | ||
| EBITDA (Operating Profit)Derived | 404 | 943 ▲ 133.4% | 1,241 ▲ 31.6% | 1,492 ▲ 20.3% | 1,849 ▲ 23.9% | 2,243 ▲ 21.3% | |
| OPM %Derived | 16.12% | 23.97% | 27.19% | 27.60% | 26.30% | 26.79% | |
120 | 313 ▲ 161.1% | 316 ▲ 1.0% | 305 ▼ 3.5% | 451 ▲ 47.9% | 633 ▲ 40.5% | ||
| Profit Before Tax (PBT) | -69 | 739 ▲ 1176.3% | 1,064 ▲ 44.0% | 1,365 ▲ 28.4% | 1,406 ▲ 3.0% | 1,676 ▲ 19.1% | |
46 | 134 ▲ 191.9% | -40 ▼ 129.7% | 308 ▲ 873.3% | 330 ▲ 7.4% | 233 ▼ 29.4% | ||
| Effective Tax %Derived | -66.79% | 18.11% | -3.74% | 22.54% | 23.50% | 13.92% | |
| Total Profit for Period | -138 | 605 ▲ 539.9% | 1,104 ▲ 82.4% | 1,058 ▼ 4.2% | 1,076 ▲ 1.7% | 1,442 ▲ 34.1% | |
| Net Profit (Owner's PAT)Derived | -138 | 605 ▲ 539.9% | 1,104 ▲ 82.4% | 1,058 ▼ 4.2% | 1,076 ▲ 1.7% | 1,442 ▲ 34.1% | |
| Net Profit Margin %Derived | -5.49% | 15.39% | 24.19% | 19.56% | 15.31% | 17.23% | |
| PAT Growth YoY %Derived | — | 539.88% | 82.38% | -4.16% | 1.72% | 34.07% | |
| Earnings Per Share (EPS ₹) | -1.42 | 6.24 ▲ 539.4% | 11.37 ▲ 82.2% | 10.88 ▼ 4.3% | 11.07 ▲ 1.7% | 14.82 ▲ 33.9% | |
| Diluted Shares Outstanding (Cr) | 97 | 97 ▲ 0.4% | 97 ▲ 0.1% | 97 ▲ 0.1% | 97 ▲ 0.0% | 97 ▲ 0.1% | |
| Share of Profit from Associates/JVs | -23 | — ▲ 100.0% | — | — | — | — | |
| Other Comprehensive Income (Net of Tax) | 1 | 3 ▲ 419.6% | -0 ▼ 118.1% | -6 ▼ 1243.8% | -5 ▲ 29.5% | -2 ▲ 65.3% | |
| Total Expenses (incl. D&A & Interest) | 2,688 | 3,320 ▲ 23.5% | 3,638 ▲ 9.6% | 4,219 ▲ 16.0% | 5,778 ▲ 37.0% | 6,860 ▲ 18.7% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 23.51% | 19.33% | 17.74% | 17.28% | 16.70% | 16.21% | |
| Other Cost % of RevenueDerived | 36.64% | 33.22% | 34.86% | 34.42% | 35.98% | 35.63% | |
| Interest Coverage (x)Derived | 1.28x | 7.15x | 12.02x | 20.82x | 9.03x | 7.64x |
Max Healthcare Institute segment analysis : revenue and profit mix.
Disclosed business segments at Max Healthcare Institute with their share of revenue and profit, switchable between consolidated and standalone reporting.
Max Healthcare Institute discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Max Healthcare Institute Ltd.
Our AI distills the core fundamental drivers supporting Max Healthcare Institute Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Max Healthcare Institute Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 21.45% substantially exceeds peer averages, demonstrating pricing power.
ROE 14.70% and ROCE 14.70% reflect efficient capital deployment and consistent returns.
Debt-to-equity 0.0032x indicates conservative leverage and fortress balance sheet.
FII ownership 54.76% signals strong institutional confidence in management quality.
Cash flow per share ₹16.78 demonstrates healthy liquidity generation capability.
Key Risks.
Latest quarterly EPS grew 7.3% YoY, moderating from historical expansion pace.
P/E ratio 77.04x suggests significant premium valuation relative to earnings.
Net profit fell from ₹319Cr to ₹308Cr, indicating quarterly profit contraction.
Stock trading near 52-week high ₹1301.70, limiting near-term upside potential.
Dividend yield 0.18% remains minimal, offering limited income to shareholders.
Flip Conditions.
Valuation risk. a P/E above 95 (~2.1× the sector multiple of 46.3) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 10% would indicate weaker capital compounding.
Max Healthcare Institute Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Max Healthcare Institute Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Max Healthcare Institute Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Max Healthcare Institute Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Max Healthcare Institute Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Max Healthcare Institute Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Max Healthcare Institute Ltd stood at 67.9% of traded volume, against a 20-day average of 56.8%.
Max Healthcare Institute announcements: results, concalls, ratings, M&A.
Filings Max Healthcare Institute sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Max Healthcare Institute files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 169 documents below.
Shareholders meeting
Max Healthcare Institute Limited has submitted the Exchange a copy Scrutinizer's report of 25th Annual General Meeting held on July 30, 2026.…
Shareholders meeting
Max Healthcare Institute Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 30, 2026
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Max Healthcare Institute Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Updates
Max Healthcare Institute Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for the financial year…
Investor decks & rating reports.
Max Healthcare Institute dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Max Healthcare Institute has declared, sequenced by announce and record date.
Max Healthcare Institute corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Max Healthcare Institute Ltd: business, sector, key facts.
What Max Healthcare Institute Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Max Healthcare Institute Ltd operates in the Hospital industry under the Healthcare sector, listed as NSE: MAXHEALTH, BSE: 543220.
Max Healthcare Institute Limited is a major provider of medical and healthcare services in India, operating a diverse network of hospitals and medical centers across the country. Their services span a wide range of specialties, encompassing advanced cardiac care, orthopedics, oncology, renal sciences, neurosciences, and various surgical disciplines such as minimal access metabolic and bariatric surgery, obstetrics, gynecology, and general surgery. The company also offers highly specialized procedures such as liver, heart, kidney, lung, and bone marrow transplants, reflecting a commitment to comprehensive and advanced medical care.
Beyond its core hospital services, Max Healthcare boasts a significant presence in ancillary healthcare sectors. Max@Home provides a convenient alternative for patients seeking health and wellness services in the comfort of their own homes, expanding accessibility and convenience. Complementing this is MaxLab, a diagnostic services arm that extends its reach beyond the company's hospital network. MaxLab utilizes various channels including collaborations with third-party hospitals to provide diagnostic services to a broader patient base.
The company's business model is built around delivering high-quality healthcare across a spectrum of services and delivery methods. This integrated approach allows Max Healthcare to cater to a wide range of patient needs, from routine check-ups and diagnostics to complex surgical procedures and long-term care. The integration of hospital services, home healthcare, and diagnostic services creates a comprehensive ecosystem that enhances patient care and expands market reach. The company's incorporation in 2001 and continued operation in Gurugram, India demonstrates a long-standing commitment to serving the Indian healthcare market.
In summary, Max Healthcare Institute Limited’s business centers around providing a wide range of medical services, leveraging an integrated model of hospital care, home healthcare, and diagnostic testing. This multifaceted approach ensures accessibility and comprehensive care across a broad patient population within the Indian healthcare landscape, and positions them as a major player in the country's healthcare industry.
Go deeper on Max Healthcare Institute
- Max Healthcare Institute resultsQuarter-by-quarter revenue, profit, EPS and margins for Max Healthcare Institute.
- Max Healthcare Institute dividendEvery dividend Max Healthcare Institute has declared, with ex-dates and yield.
- Max Healthcare Institute shareholdingPromoter, FII and DII holding in Max Healthcare Institute, quarter by quarter.
- Max Healthcare Institute financialsMax Healthcare Institute profit & loss, balance sheet and cash flow by year.
- Max Healthcare Institute technical analysisPivots, CPR and live indicator readings for Max Healthcare Institute.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Max Healthcare Institute Ltd (MAXHEALTH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Max Healthcare Institute Ltd (MAXHEALTH)?
The current share price of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1,072.40. Today, the stock has declined by ₹7.60 (0.7%), trading in a range of ₹1,064.10 to ₹1,079.50. The stock opened at ₹1,079.50 with a trading volume of 17,28,681 shares.
02Is Max Healthcare Institute Ltd stock a good investment for long-term?
Max Healthcare Institute Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹0, P/E ratio of 72.87, ROE of 14.7%, and ROCE of 14.7%. The dividend yield stands at 0.18%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Max Healthcare Institute Ltd stock?
The 52-week high price of Max Healthcare Institute Ltd (MAXHEALTH) is ₹1,301.70, while the 52-week low is ₹903.00. Currently trading at ₹1,072.40, the stock is 18.76% above its 52-week low and 17.62% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Max Healthcare Institute Ltd stock at the current price?
Whether to buy Max Healthcare Institute Ltd stock at ₹1,072.40 depends on multiple factors. The stock is currently trading with a P/E ratio of 72.87 and P/B ratio of 9.78. Today's performance shows a loss of 0.7%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Max Healthcare Institute Ltd and when is the next dividend?
Max Healthcare Institute Ltd offers a dividend yield of 0.18%, which means for every ₹100 invested at the current price of ₹1,072.40, you can expect to receive approximately ₹0.18 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Max Healthcare Institute Ltd?
Max Healthcare Institute Ltd's key financial metrics include: P/E Ratio: 72.87, P/B Ratio: 9.78, ROE: 14.7%, ROCE: 14.7%, Dividend Yield: 0.18%, EPS: ₹14.80, Book Value: ₹110.00, and Debt-to-Equity: 0.32. The company's market cap stands at ₹0. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Max Healthcare Institute Ltd stock performing today in the market?
Max Healthcare Institute Ltd stock opened at ₹1,079.50 and is currently trading at ₹1,072.40, showing a decline of ₹7.60 (0.7%). The intraday high is ₹1,079.50 and low is ₹1,064.10. The trading volume stands at 17,28,681 shares, indicating strong market participation today.
08What is the P/E ratio of Max Healthcare Institute Ltd and what does it indicate?
Max Healthcare Institute Ltd has a Price-to-Earnings (P/E) ratio of 72.87, which means investors are willing to pay 72.87 for every ₹1 of earnings. With an EPS of ₹14.80, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Max Healthcare Institute Ltd (MAXHEALTH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.